Journal of Endocrinology and Metabolism, ISSN 1923-2861 print, 1923-287X online, Open Access
Article copyright, the authors; Journal compilation copyright, J Endocrinol Metab and Elmer Press Inc
Journal website http://www.jofem.org

Original Article

Volume 7, Number 1, February 2017, pages 25-30


Evaluation of the Efficacy of Potassium Iodide Preparation for Radioactive Iodine Therapy in Graves’ Disease: A Retrospective Chart Review

Figure

Figure 1.
Figure 1. The protocol of this study.

Tables

Table 1. Clinical Features of KI and MMI Groups
 
KIMMIP-value
Age (mean ± SD)41.9 ± 11.439.2 ± 13.6n.s.
Gender (male/female)2:90:13n.s.
Smoking (yes/no)3:82:11n.s.
Duration of GD treatment (median (25-75%)), months16.0 (3.0 - 52.0)37.0 (16.5 - 58.5)n.s.
FT4 before discontinuation of KI or MMI (median (25-75%)), ng/dL2.11 (1.58 - 2.48)1.21 (1.00 - 1.49)P < 0.05
Method of RAIT (fixed dose/calculated dose)8:33:10P < 0.05
Dose of drugs before RAIT, (median (25-75%)), mg-
  MMI (n = 0:13)-12.5 (7.5 - 16.3)
  KI (n = 11:0)150 (100 - 200)-

 

Table 2. Results of This Study
 
KIMMIP-value
RAIU (median (25-75%)), %29.9 (20.9 - 32.6)62.9 (55.6 - 72.3)0.0018*
Thyroid gland weight (median (25-75%)), g24.1 (16.9 - 32.2)32.7 (23.5 - 42.2)0.1396
Dose of 131-I (median (25-75%)), mCi13.0 (10.9 - 13.0)7.5 (5.5 - 11.9)0.0037*
Dose of 131-I based on thyroid gland weight (median (25-75%)), μCi/g144.8 (121.8 - 176.6)156.9 (118.7 - 193.9)0.8393
FT4 at RAIT (median (25-75%)), ng/dL2.25 (1.79 - 4.02)1.47 (0.89 - 1.69)0.0034*
Difference in FT4 between before drug discontinuation and at RAIT (median (25-75%)), ng/dL0.54 (-0.05 - 1.70)0.08 (-0.34 - 0.49)0.1557
Thyroid function at 1 year after RAIT (R/non-R)8:35:80.0932
Thyroid gland weight at 1 year after RAIT (median (25-75%)), g5.3 (3.2 - 6.4)8.9 (6.7 - 12.5)0.0065*
Dose of drugs at 1 year after RAIT (median (25-75%)), mg
  MMI (n = 0:13)-2.5 (0 - 5)
  KI (n = 11:0)0 (0-25)-